JSPR – jasper therapeutics, inc. - class a (US:NASDAQ)
Stock Stats
News
We're Keeping An Eye On Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Rate [Yahoo! Finance]
Is Jasper Therapeutics (JSPR) the Best Multibagger Stock to Buy Heading into 2025? [Yahoo! Finance]
Jasper Therapeutics to Participate at Upcoming Investor Conferences
Jasper Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $65.00 price target on the stock.
Form SC 13G/A Jasper Therapeutics, Filed by: Avidity Partners Management LP
Form SC 13G/A Jasper Therapeutics, Filed by: Soleus Private Equity Fund III, L.P.
Form SC 13G Jasper Therapeutics, Filed by: BlackRock, Inc.
Form 8-K Jasper Therapeutics, For: Nov 07
Form 10-Q Jasper Therapeutics, For: Sep 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.